GrowerIQ — Wilcompute Systems Group Inc.
Seed-to-Sale Cannabis SaaS — Cultivation, Compliance, QMS & CRM in One Platform · Ontario, Canada
GSV Investment
C$2.26MCT
2 tranches → equity
Pre-Money Val.
C$10.0MTS
6.5x run-rate ARR
ARR (Jan 2024)
C$4.0MJAN24
Post-Ample acquisition
Software Gross Margin
~80%OCT23
Sep 2023 (SaaS-only)
GSV Ownership (FD)
17.32%CT
Post-note conversion
Financial Performance
ARR Trajectory & Key Metrics
Sources: Deal Memo (Aug 2022), Apr/Oct 2023 Board Decks, Jan 2024 Board Deck
Annual Recurring Revenue (C$M)
Key Financial Metrics
ARR (Jun '22)
C$1.5M
At investment close
ARR Growth (SaaS)
94% YoY
2021 → 2022
Software Gross Margin
~80%
Sep 2023 (SaaS-only)
Monthly Burn
C$59K
Q3 2023 (↓ 55%)
ACV
C$21K
9.9 mo CAC payback
Churn (Q3 '23)
0.21%/mo
↓ from 1.54% (6mo avg)
| Period | ARR | Burn/mo | Churn/mo |
|---|---|---|---|
| Jun 2022 (invest.) | C$1.50M | — | — |
| Mar 2023 | C$1.67M | ~C$133K avg | 0.95% |
| Sep 2023 | C$1.91M | C$59K | 0.21% |
| Jan 2024 (post-Ample) | C$4.0M | ~BEP | 1.3% |
Sales Performance — Q4 2023
New ARR (Q4)
C$90K
23 proposals sent
Win Rate
55%
10 wins / 18 props.
Open Pipeline
C$3.4M
51 open SW opps
Days to Win
88 days
↓ from 119 avg
Sales Efficiency
0.48x
YTD (2022)
Customer Sat.
4.9 / 5
Q4 2023 CSAT
Investment Structure
Deal Terms & Capitalization
Sources: GSV Term Sheet (Apr 2022), Dec 2023 Convertible Note, Pro Forma Cap Table (Oct 2025)
Round 1 — July 2022 Note
Investor EntityGSV Investors II LP
Principal (GSV)C$1,600,000
Total Round SizeC$2,983,689
Closing DateJuly 21, 2022
Interest Rate8% p.a. (monthly comp.)
Valuation CapC$10,000,000
Discount20% off lowest price
Conv. Price / ShareC$0.90
Shares Issued (GSV)2,258,425 Series 1
Round 2 — December 2023 Note
Principal (GSV)C$659,979
Total Round SizeC$1,168,849
Closing DateDecember 21, 2023
Interest Rate8% p.a. (monthly comp.)
Valuation CapC$20,000,000 (→C$10M)
Conv. Price / ShareC$1.31
Shares Issued (GSV)569,913 Series 2
Equity ConversionNovember 2025
Total GSV Position
Total Principal InvestedC$2,259,979
Total Shares (FD)2,828,338
GSV FD Ownership17.32%
Liquidation Preference1x OIP + 8% div.
Pro Forma Cap Table — Post Conversion (Oct 2025)
| Shareholder | Class | FD Shares | FD % |
|---|---|---|---|
| Robert James Wilson | Common | 5,001,010 | 30.62% |
| Andrew James Wilson | Common | 5,000,000 | 30.61% |
| GSV Investors II LP | Class C Pref | 2,828,338 | 17.32% |
| ESOP (Allocated) | Options | 744,538 | 4.56% |
| MaRS IAF | Class C Pref | 813,698 | 4.98% |
| LAGO D9 Equity, LLC | Class C Pref | 570,029 | 3.49% |
| ESOP (Unallocated) | Options | 366,686 | 2.24% |
| 1807378 Ontario Inc. | Class C Pref | 282,303 | 1.73% |
| 3.0 Corp. | Class C Pref | 215,883 | 1.32% |
| GTMFUND, LP | Class C Pref | 182,487 | 1.12% |
| Harjot Ghai Holdings | Class C Pref | 141,151 | 0.86% |
| Kharkhourin Holdings | Class C Pref | 141,151 | 0.86% |
| Gaingels Spark III LLC | Class C Pref | 45,817 | 0.28% |
| TOTAL (FD) | 16,333,091 | 100% |
Cap Table (Fully Diluted)
Business Overview
Product, Market & Competitive Position
Sources: Deal Memo (Aug 2022), GrowerIQ Data Room
Product Suite
Cultivation Module: Batch tracking, environmental monitoring, growth stage management, and yield optimization for indoor/outdoor facilities.
Manufacturing & Inventory: Full production workflow, inventory control, lot traceability, and waste tracking aligned to Health Canada requirements.
QMS (Quality Management): SOPs, corrective actions (CAPA), EU GMP compliance documentation, and audit trail management.
CRM & Orders: Customer relationship management, order management, and sales pipeline integrated with production data.
Regulatory Traceability: Seed-to-sale traceability built for Canadian regulations — signed customers in Portugal, Barbados, and Morocco; Germany and Austria in active government pipeline.
Pricing & Market
| Facility Type | Size | Monthly Price |
|---|---|---|
| Indoor | 2,000 sq ft base | C$1,499/mo |
| Indoor | 5,000–10,000 sq ft | C$1,999/mo |
| Outdoor | 5 acres base | C$1,799/mo |
| Outdoor | 10 acres | C$2,399/mo |
| Range | C$1,499–C$5,000/mo | |
Market Opportunity
| Market | Size / Projection |
|---|---|
| Legal cannabis global sales (2022E) | US$33B+ |
| North America TAM (2026E) | US$52B |
| Canadian market (primary) | 57% of revenue |
| Portugal | 11%+ of revenue |
| Active international markets | 10+ countries |
Competitive Differentiation
First cannabis platform to integrate sensors, controls, QMS, and ERP into a single interface. 21%+ of current clients converted from a competing platform. Unlimited user seats at flat pricing. Canadian regulatory expertise now exported globally.
M&A Activity
Ample Organics Acquisition
Source: Apr 2023 Board Deck (LOI), Jan 2024 Board Deck (post-close)
Strategic Rationale: Ample Organics was GrowerIQ's primary Canadian competitor. Acquisition eliminated churn risk, added 60 enterprise customers, and nearly doubled ARR overnight.
Deal Metrics: Agreed price ~C$616K (1.2x trailing EBITDA, 0.37x ARR). Ample's EBITDA at close was ~C$506K/yr (+C$42K/mo per Oct 2023 Board); ARR at close (Nov 2023) was ~C$2.2M — acquired at an exceptional valuation. (Note: Ample's 2022 EBITDA was reported as C$1.2M in Apr 2023 preliminary data; deal was priced on trailing EBITDA at close.)
ARR Impact: GrowerIQ went from C$1.91M ARR (Sep 2023) to C$4.0M ARR (Jan 2024) — a 109% step-change driven entirely by the acquisition.
Synergies: C$154.9K in annualized cost savings realized — AWS consolidation ($70.9K), office space ($12K), infrastructure monitoring ($72K).
| Metric | Ample (Pre) | Combined (Jan '24) |
|---|---|---|
| ARR | ~C$2.2M | C$4.0M |
| Customers | 60+ | 60+ (added) |
| EBITDA at Close | ~C$506K/yr | — |
| Acquisition Price | ~C$616K | — |
| Price / ARR | 0.37x | — |
| Price / EBITDA | 1.2x | — |
| Staff Acquired | 7 | — |
| Annual Cost Savings | C$154.9K |
Acquisition Close
Closed Nov 2023. Integration complete by Jan 2024. Post-acquisition combined ARR target of C$4.5M by EOY 2023 per Oct 2023 board deck.
Leadership
Management Team & Board
Source: Deal Memo (Aug 2022), Investment Documents
AW
Andrew Wilson
CEO & Co-Founder — 30.61% FD
Two-time founder with an MBA. Background in implementing technology solutions for clients of all sizes. Wilcompute Systems Group — the parent entity Andrew leads — has over 25 years of history with Fortune 500 relationships including Hewlett Packard.
RW
Robert Wilson
Founder — 30.62% FD
Co-founder and majority shareholder of Wilcompute Systems Group Inc. (GrowerIQ's parent entity).
DK
Daniel Kain
Chief Operating Officer
Joined as COO to drive operational scale and process maturity. Manages cross-functional coordination across engineering, customer success, and sales teams.
RP
Rob Perry
VP of Sales
MBA. Former cannabis executive with enterprise software sales background in financial services sector. Leads all revenue generation, inbound pipeline development, and international market expansion.
MC
Marcos Cordeiro
Head of Engineering (departed Dec 2023)
M.Sc. Computer Science with 18+ years leading engineering teams. Technical lead for GrowerIQ's platform at time of investment. Departed December 2023 per Jan 2024 Board Deck.
GS
Golden Section
Investor — Board Observer / Nominee
Dougal Cameron (Managing Director) led the investment and signed both notes. Andrew Smith (General Partner) serves as board nominee per the note conversion agreement.
Investment Thesis & Risk Assessment
Thesis Pillars & Key Risks
Source: Deal Memo (Aug 2022), Board Decks (2023–2024)
Investment Thesis
Regulatory Moat via Canadian Framework Export: Canada built the world's most sophisticated cannabis regulatory playbook. GrowerIQ's compliance tooling follows it globally — every new legalization event in a Canada-modelled country generates inbound leads.
First Truly Integrated Platform: Uniquely combines Cultivation, Manufacturing, QMS, CRM, and ERP in one interface. 21%+ of clients switched from a competitor — proof of superior product-market fit.
SaaS Unit Economics: 80–92% software gross margin, 9.9-month CAC payback, 94% SaaS ARR YoY growth. High-margin SaaS increasingly dominant as consulting/hardware revenue streams decline in proportion.
Wilcompute Backbone: 25+ years of enterprise software delivery, Fortune 500 relationships, and operational infrastructure de-risk the founder quality concern typical of early-stage SaaS.
Ample Acquisition Accelerated Scale: Eliminated primary Canadian competitor, doubled ARR to C$4M, and demonstrated capital efficiency at 0.37x ARR / 1.2x EBITDA deal price.
Risk Assessment
▲ HIGH
Tech Infrastructure Modernization: Core platform was assessed at MVP level at investment (2022). Architecture needs modernization for scale. GS product team engaged to support systematic improvement.
▲ HIGH
Cannabis Industry Concentration: 100% revenue exposure to a single regulated industry. Banking restrictions, federal legality (US), and regulatory shifts create sector-specific risks.
MED
International Pricing Sensitivity: Entry into low-labor-cost markets requires price reductions. Portugal (11%+ of revenue) and LATAM markets have lower willingness-to-pay than Canadian facilities.
MED
Customer Churn: Peaked at 2.9%/mo in Q4 2022, improved to 0.95%/mo by Q1 2023, and further to 0.21%/mo by Q3 2023. Key churn drivers: financial distress of cannabis operators, not platform dissatisfaction.
MED
CTO Gap: As of investment (2022), no dedicated CTO. Andrew Wilson transitioning from technical to strategic focus while tech team buildout is ongoing.
LOW
Global Legalization Timeline: Revenue catalysts tied to new country legalizations (Germany, Morocco, etc.) are uncertain in timing and pricing impact.
Exit Analysis
Return Scenarios & SaaS Maturity
Source: Deal Memo (Aug 2022) — GS proprietary SaaS Maturity Rubric
Exit Scenarios — GSV C$1.6M Investment
| Scenario | ARR at Exit | Multiple | Exit Val. | MOIC | IRR |
|---|---|---|---|---|---|
| Base Case | C$10M | 8x ARR | C$80M | ~8x | ~51% |
| Exit Parameter | Assumption |
|---|---|
| Target Exit Horizon | 5 years from close |
| Exit Strategy | Strategic acquisition (AgTech / cannabis ERP) |
| Target ARR at Exit | C$10M (base) |
| Exit Multiple | 8x run-rate ARR |
| GSV FD Ownership | 17.32% |
| Implied Proceeds (Base) | ~C$13.9M to GSV |
Strategic Acquirer Landscape
Post-Ample acquisition, GrowerIQ is the dominant Canadian cannabis SaaS vendor. Potential acquirers include major AgTech platforms, cannabis ERP consolidators, or pharma compliance software companies seeking regulated market entry. Akerna's acquisition of Ample Organics (prior to GrowerIQ's competing bid) validates the M&A consolidation dynamic in the cannabis SaaS sector.
GS SaaS Maturity Rubric — Investment Date (2022)
Rubric Commentary
Leadership (7): Founder has relevant experience across cannabis, entrepreneurship, and software. Tech (6): Functional engineering with modernization needed. Customers (7): Nearly 100% inbound growth with 94% SaaS ARR growth validates PMF. Capital (4): C$3M raise was sizable relative to ARR — capital efficiency a focus area. Revenue (6): C$1.1M USD ARR at investment. Operations (7): CEO capability combined with Wilcompute's 25-year infrastructure is strong.
GP Recommendation — Invest C$1.6M · Convertible Note → Class C Preferred
Golden Section recommends investing C$1,600,000 in Wilcompute Systems Group (GrowerIQ) via secured convertible note at a C$10M valuation cap (6.5x run-rate ARR at close). GrowerIQ is the only cannabis management platform that integrates the full facility stack — cultivation, QMS, CRM, and traceability — in a single interface, purpose-built for compliance-heavy regulated markets. With 94% YoY SaaS ARR growth, an 80%+ software gross margin profile, and inbound international demand driven by regulatory framework exports, this is a well-priced entry into a capital-efficient cannabis SaaS leader. A subsequent C$659K note (Dec 2023) was added to support the Ample Organics acquisition, which at 0.37x ARR was one of the most capital-efficient consolidation moves in the portfolio. Both notes converted to Class C Preferred Shares in November 2025, giving GSV 17.32% fully diluted ownership. Base exit: C$80M at 8x ARR run-rate → 8x MOIC / ~51% IRR over 5 years.
Total GSV Investment
C$2,259,979
2 tranches · Jul 2022 + Dec 2023 · Converted Nov 2025
Base Exit (8x ARR)
8x MOIC · ~51% IRR
C$80M exit · C$10M ARR · 5yr horizon
GSV Ownership (FD)
17.32%
2,828,338 Class C Pref shares · 1x liq. pref + 8% div.
ARR at Conversion
C$4.0M (Jan 2024, post-Ample). Pre-investment ARR was C$1.5M. 167% growth during holding period.
Key Value Drivers
Ample acquisition (0.37x ARR), global regulatory tailwinds, Wilcompute IP base, 80%+ software gross margins
Primary Risks
Tech modernization needed; cannabis industry concentration; international pricing compression
Source Documents
DMGrowerIQ Deal Memo — Golden Section long-form memo, Aug 2022
TSGSV Term Sheet — Partner Preferred Stock terms, Apr 22, 2022
CTPro Forma Cap Table — Note Conversion — Wilcompute Systems Group, Oct 8, 2025
JAN24GrowerIQ Board Deck — Jan 2024 — Q4 2023 results, Ample integration
OCT23GrowerIQ Board Deck — Oct 2023 — Q3 2023 financials and sales metrics
APR23GrowerIQ Board Deck — Apr 2023 — Q1 2023, Ample LOI discussion
CN23Secured Convertible Promissory Note (Dec 2023) — GSV Investors II LP, C$659,979.10
Derek AI
GrowerIQ Intelligence